Clinical Trial Update: Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating meta-iodobenzylguanidine scintigraphy imaging in patients with heart failure compared with controls, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: GE Healthcare | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED | Results posted: 2016-12-13